Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. - Wikidata - wikimedia - TriplyDB

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

http://www.wikidata.org/entity/Q37208100

about

Atrial fibrillation: effects beyond the atrium?EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation Atrial fibrillation as a prognostic indicator of myocardial infarction and cardiovascular death: a systematic review and meta-analysis Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease.High molecular mass proteomics analyses of left ventricle from rats subjected to differential swimming training Multiple biomarkers and atrial fibrillation in the general population Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury.Sum of effects of myocardial ischemia followed by electrically induced tachycardia on myocardial function Chronic heart failure and the substrate for atrial fibrillation.Impaired Erythrocyte Deformability in Patients with Coronary Risk Factors: Significance of Nonvalvular Atrial Fibrillation.The Relationship Between Pericardial Fat and Atrial Fibrillation.The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation.The pharmaceutical pipeline for atrial fibrillation.Novel molecular targets for atrial fibrillation therapy.Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.Oxidative stress-mediated effects of angiotensin II in the cardiovascular system Alterations in atrial perfusion during atrial fibrillation.Prognostic value of elevated high-sensitivity cardiac troponin T in patients admitted to an emergency department with atrial fibrillation.Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction.Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs.[AFNET. A translational research network develops into an academic research organization].Human electronegative low-density lipoprotein modulates cardiac repolarization via LOX-1-mediated alteration of sarcolemmal ion channels.Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling.Pleiotropic actions of amiodarone: still puzzling after half a century.Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoam Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference.Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation.EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

P2860

Q26864877-A5AC5926-445B-4D2A-A67B-3BBA475B4B7B Q30375302-7FD00846-59B7-4D5B-8369-2E981E4858E0 Q30819519-D2978866-0DBE-4A55-AD88-92F8F0B30BDC Q33794241-97527244-5E0F-4A36-90A7-C2C9A2901023 Q33846316-9108E8CE-3EB9-4926-8E92-71E867FB52C2 Q34403884-B226E46D-4C70-4527-BDD8-E3D8B17705A0 Q34525092-E7E09FF5-5209-42A1-A396-AFD5F06053F5 Q36108848-410BDE8F-314E-4065-9AEB-CBA65D03242D Q36260872-74297F88-7962-45B9-A90B-D8F32D1342F3 Q36954716-80D2F84E-9F1F-4CA7-BAF3-536DE23FA7DF Q37385641-8CB1E99D-F34C-498F-AE95-B425F9FA27A4 Q37495734-BA203C47-510F-45CD-86AE-9402FE75DF5A Q37495937-9B3ED203-368B-4639-A8B6-ACABDD73E3DE Q37799958-4099605C-834A-4D69-A651-30F42D5EB30B Q37812402-F9F828FD-1A17-49CF-A71A-5DDCEE16B53F Q37821928-8D6AB67F-ECF7-4275-A26D-A96E4AA73471 Q37998312-06442245-BD60-4D43-AAD2-4425C6479AE4 Q38025390-DB627409-D682-4040-BA41-DAD5135BA364 Q38192646-B1CAC181-B17B-45F8-BAC8-56DB56E54A27 Q38234147-39753FD0-B7C1-47E0-980A-0357BD3B42B9 Q38377313-63CC3D73-CE65-4F23-ADCF-A6D522088624 Q38703115-2CB10BE8-33EB-4816-8779-FF4F91D53C07 Q39193717-F438ED63-E7B3-4100-AD26-E611C205CD17 Q39439506-DABFDC17-EC4F-4423-9B15-CA48F4FA0AFD Q40852337-6F20537D-A0E0-43CC-8B47-118AD5C46CEC Q41542147-425DAF25-ADF1-4CFE-A900-AB43FC724F16 Q42923039-5D981844-A6E4-40F3-9387-6796F66D5E36 Q43138277-E55C9FC3-2229-4DC2-8797-8E788C580B3A Q46907800-C04D4864-A14D-4D3A-B64C-D97911310369 Q47775639-AF7BAC48-1166-4713-8222-F08DEF8CE96D Q47883450-F9C3C809-079C-4703-AEB7-D85E115C2318 Q53318291-BC5E12F0-351D-48C4-9CE2-2FF7E613AC33 Q55638585-423B67FB-E2B2-4C9F-AE5B-1896A19CA427

P2860

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

http://www.wikidata.org/entity/Q37208100

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acute atrial tachyarrhythmia i ...... normalities in the ventricles.

@en

Acute atrial tachyarrhythmia i ...... normalities in the ventricles.

@nl

type

label

Acute atrial tachyarrhythmia i ...... normalities in the ventricles.

@en

Acute atrial tachyarrhythmia i ...... normalities in the ventricles.

@nl

prefLabel

Acute atrial tachyarrhythmia i ...... normalities in the ventricles.

@en

Acute atrial tachyarrhythmia i ...... normalities in the ventricles.

@nl

P1433

Q37208100-88127E61-718C-496B-AA88-73CF95EFE2AB

P1476

Q37208100-6883BD80-0752-4269-95A0-17F0CD1DD1AE

P2093

Q37208100-2C5C6D7D-0531-4F7B-AAF3-FA210E4DB35A

Q37208100-3F9FECE0-9FC5-4A81-8222-561DBD88F2D6

Q37208100-53268B22-2A0D-4FB7-99E9-CDA587DDF9E7

Q37208100-597EE4D0-20DC-4F0A-B80C-DF73DDCB3639

Q37208100-648B9935-E906-4E0F-BC21-85DCCB140451

Q37208100-686671BF-007A-437B-855F-BE6ED230796F

Q37208100-89D72994-6D4E-4215-9786-85DD2BDEDB80

Q37208100-98E8DBCE-4936-471B-A102-2D44C2CE0F09

Q37208100-9DAFADF2-45A1-4BF5-8C54-A7629102BF04

Q37208100-DF69B7E7-C925-461A-82D7-2166BAAC2946

P2860

Q37208100-033EAFAA-036D-479E-B130-1D9874E9E35F

Q37208100-046F01DE-A94B-4095-B83D-25D1BBD53AAD

Q37208100-0504E25C-CA6E-4955-8E71-6D3ACC44A9F6

Q37208100-140C5C27-CFD3-4005-AA83-90D8CDBE4F47

Q37208100-19444B4A-B4FB-475D-B84B-662ED066510C

Q37208100-2472B97E-7B1B-4D7D-88AC-5FD84FF697A3

Q37208100-312DF856-3B15-4766-A9A0-298F51426BCA

Q37208100-315FE2AB-1CA6-467B-BFB1-5494BE1BC60A

Q37208100-3544B4D0-7114-4466-982E-4A1001E7711C

Q37208100-35AA5C0C-250C-4F08-8715-26459AE46574

P304

Q37208100-3701F31A-5FD2-4B35-A28A-21298F057390

P31

Q37208100-71A317B7-3DA6-4CF1-A4A4-305A47503D87

P356

Q37208100-8B16190B-7706-4CEA-8C53-E93B1A873185

P433

Q37208100-2CC7349C-3B92-4205-8CB7-5258F5285093

P478

Q37208100-F93CA1F1-47D6-4FC3-AA6C-28FC346D7479

P50

Q37208100-2CFEF37C-2368-4C87-A677-30A9E2AC420D

P577

Q37208100-B101B8D0-DB8E-4E2E-8D52-80C6D70FC652

P5875

Q37208100-6EE84FF6-D08F-4736-A7D4-BFEF246C80F6

P698

Q37208100-A0C4F64D-F1FB-458E-8892-49B6018B9B6B

P932

Q37208100-E8148060-A872-42B9-AF25-F7D34A894211

P356

P1433

European Heart Journal

P1476

Acute atrial tachyarrhythmia i ...... bnormalities in the ventricles

@en

P2093

Alicja Bukowska

http://www.w3.org/2001/XMLSchema#string

Andreas Goette

http://www.w3.org/2001/XMLSchema#string

Carmen Wolke

http://www.w3.org/2001/XMLSchema#string

Denis Strugala

http://www.w3.org/2001/XMLSchema#string

Dobromir Dobrev

http://www.w3.org/2001/XMLSchema#string

Friedrich-Wilhelm Röhl

http://www.w3.org/2001/XMLSchema#string

Henning Morawietz

http://www.w3.org/2001/XMLSchema#string

Ingrid Wiswedel

http://www.w3.org/2001/XMLSchema#string

Jan Pfeiffenberger

http://www.w3.org/2001/XMLSchema#string

Sybille Bergmann

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

A comparison of rate control and rhythm control in patients with atrial fibrillation.

LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.

Phospholamban: a crucial regulator of cardiac contractility.

Altered cardiac myocyte Ca regulation in heart failure.

Coronary microvascular dysfunction.

P304

1411-1420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHP046

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24185511

http://www.w3.org/2001/XMLSchema#string

P698

19269986

http://www.w3.org/2001/XMLSchema#string

P932

2688683

http://www.w3.org/2001/XMLSchema#string